Insight
Back
Insight
Investment Strategy
Competencies
Empowering people through business investment.
Sectors
Back
Sectors
Overview
Life Sciences
Software
Semiconductor
AI
Finance
Real Estate
Empowering people through business investment.
Portfolio
Back
Portfolio
Investment Portfolio
Empowering people through business investment.
Team
Back
Team
Team
Portfolio Company Leadership
Operating Partners
Empowering people through business investment.
Firm
Back
Firm
Milestones
Locations
Core Values
Citizenship
Empowering people through business investment.
News
Back
News
Press
Empowering people through business investment.
Contact
News
Press
Life Sciences
BioCina awarded Grants to develop enabling technologies for manufacture of precision mRNA vaccines
26 April 2023
(MIAMI and ADELAIDE April 26, 2023) BioCina, a leading contract development and manufacturing organization (CDMO) is pleased to announce that it has been awarded a $5.0m AUD grant under the Federal Government’s Medical Research Future Fund (MRFF) Grants scheme to fund work with its industry partners to develop enabling technologies for manufacture of precision mRNA vaccines. ..
read more
Recent
Life Sciences
Bridgewest Perth Pharma to commercialize Sterile Injectable drugs under LumaCina business unit
25 April 2023
Life Sciences
Bridgewest Group launches NovaCina, new sterile injectable CDMO
05 April 2023
Life Sciences
Bridgewest Group completes acquisition of sterile injectable manufacturing plant in Western Australia fr...
04 April 2023
Life Sciences
Mark W. Womack Joins BioCina as CEO
14 March 2023
Life Sciences
BioViros' new laboratory marks New Zealand's first lentiviral vector CDMO
09 March 2023
Software
Projectworks teams up as QuickBooks Solution Provider for US professional services
06 March 2023
Life Sciences
BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3182, a CAB-EpCAMxCAB-CD3 ...
23 February 2023
AI
TheTestMart is Leveraging ChatGPT
21 February 2023
Life Sciences
Dr. Andi Grant is appointed to CEO at BioOra
02 February 2023
Life Sciences
Bio4t2 announces first patient infused with CAR-T targeting solid tumors
10 January 2023
Life Sciences
New Clinical Research Organisation BioValeo has been founded to support the NZ biotech industry
17 November 2022
Life Sciences
A million times smaller than a dot, Nanophage Tech's nanorods could change the future of diagnostics
15 November 2022
Life Sciences
11 November 2022
Bridgewest Group inks deal with Pfizer to acquire injectable manufacturing plant in Western Australia
AI
08 November 2022
Macso Technologies Harnessing Artificial Intelligence to detect animal illnesses and improve welfare
Life Sciences
08 November 2022
Himalaya Therapeutics Highlights Recent Clinical Progress
Life Sciences
03 November 2022
BioViros to fill gap in market and support cell therapies
Software
16 October 2022
Meet Pontis, the newest Croatian tech miracle
Corporate
30 June 2022
Bridgewest Group adds new members to management team
Life Sciences
13 June 2022
BioCina announces opening of new GMP plasmid DNA manufacturing suite
Life Sciences
05 April 2022
BioCina awarded Grant to advance RNA vaccines and therapeutics
Life Sciences
14 February 2022
BioDuro-Sundia appoints Kent Payne CEO
Life Sciences
26 January 2022
Rick Hancock named as Board Chairman for BioCina
Software, AI
30 November 2021
Amid Rapid U.S. Growth, Provoke Solutions Appoints Jenna Chamra as CMO and SVP Global Consulting
Life Sciences
30 November 2021
BioCina officially opens full-service CDMO in Adelaide, Australia, including mRNA and pDNA cGMP manufacturing
Life Sciences
08 November 2021
BioDuro-Sundia Acquires 2nd US-based Commercial Drug Product Manufacturing Facility along with Commercial Supply Agreement.
Life Sciences
05 October 2021
BioCina expands into full-service CDMO with full control of Pfizer manufacturing facility in Adelaide, Australia
Software, AI
07 September 2021
Amid Rapid U.S. Growth, Provoke Solutions Appoints Brendon Ford as COO
Software, AI
26 August 2021
Provoke Solutions Appoints Jason Court to Lead Customer Acquisition in the Asia-Pacific Market
Life Sciences
30 June 2021
BioCina expands expertise of Board of Directors with new member Sven Lee
Life Sciences
11 May 2021
A shot at vaccine self-reliance via BioCina and University of Adelaide partnership
Software, AI
11 May 2021
Bridgewest Ventures NZ Closes Third New Venture
Life Sciences
04 May 2021
BioArdis appoints Kedar Muley as Chief Business Officer and Acting Chief Executive Officer
Software, AI
22 April 2021
Provoke Solutions Appoints Andy Lin CEO to Drive New Growth in U.S. Market
Life Sciences
13 April 2021
BioDuro-Sundia Completes First GMP Drug Product Manufacturing at New China Site
Life Sciences
22 February 2021
BioAtla Conditionally Active Biologic Antibody Design And Functionality For Cancer Treatment Described In Leading Scientific Journal Peer-Reviewed Paper
Life Sciences
09 February 2021
BioDuro-Sundia Announces New CEO
Life Sciences
18 December 2020
BioAtla Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Life Sciences
03 December 2020
BioDuro & Silexon Form Strategic Collaboration to Develop New Anti-Cancer Drugs
Life Sciences
06 October 2020
BioAtla and BeiGene Revise Global Development and Commercialization Agreement
Life Sciences
01 September 2020
Bridgewest Australia Holdings LLC Acquires Pfizer manufacturing facility in Adelaide, Australia
Life Sciences
15 July 2020
BioAtla Raises $72.5 Million In Series D Financing
Life Sciences
17 April 2020
BioDuro Breaks Ground on 300,000 sq ft Facility in Jiangsu China
Life Sciences
03 April 2020
Shenogen enters into an Exclusive License with BioArdis to Develop and Commercialize Novel FGFR4 Kinase Inhibitor for Asian Market
Life Sciences
26 March 2020
BioDuro Initiates Effort to Develop COVID-19 Nanobody Therapeutic
Software, AI, Semiconductor, Life Sciences
13 January 2020
Bridgewest Ventures welcomes opportunity to incubate deep tech in NZ
Software, AI
21 March 2019
Bridgewest Group Acquires New Zealand-Based Provoke Solutions
Life Sciences
27 January 2019
BioDuro partners with Advent International
Semiconductor, AI
29 November 2018
Endura Technologies And UNISOC Announce Commercial Partnership
Life Sciences
09 October 2018
BioDuro Launches New Drug Discovery Site in San Diego, CA,
Life Sciences
19 March 2018
BioDuro Collaboration with Pfizer Inc. Leads to Creation of a Shelf-Stable Fluorosulfation Reagent
Life Sciences
05 March 2018
BioDuro Completes Acquisition of Molecular Response to Accelerate Translational Oncology Capabilities
Life Sciences
30 January 2018
BioDuro announces cooperation agreement with Porton Pharma Solutions
Semiconductor, AI
05 December 2017
Endura Technologies Announces Availability of ET7730 - Industry's Smallest 6A Embedded Voltage Regulator (eVR™) Solution in 1mm(3) Volume, Operating at 130MHz
Life Sciences
29 March 2017
BioDuro launches humanized tumor microenvironment, three-dimensional drug screening and patient-derived xenograft verification platform: hTME-3DX Screen and Verify™
Life Sciences
08 November 2016
BioDuro, LLC Increases Spray Dried Drug Product Manufacturing Capacity
Life Sciences
06 September 2016
BioDuro completes infrastructure expansion in Shanghai to accommodate 130 additional chemistry and biology staff for its integrated drug discovery and development programs and to enable rapid scale up for process-chemistry
Semiconductor
04 May 2016
Endura Technologies and MediaTek Inc. Announce Commercial Partnership
Life Sciences
07 January 2016
BioDuro, LLC Adds Industry Veteran CFO To Executive Team
Life Sciences
11 November 2015
BioDuro, LLC Announces Merger with Formex, LLC, and New Leadership
Life Sciences
11 November 2014
BioAtla Partners With BioDuro To Advance Two Proprietary Antibody Therapeutics In China
Life Sciences
14 October 2014
BioAtla Receives Broad Patent For Antibody Development